Ivana Filipovic

Dr. Ivana Filipovic


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2016 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IFIvana Filipovic
Ivana Filipovic
Marco CaminatiMarco Caminati
Marco Caminati
GKGordana Kostić
Gordana Kostić
ĐFĐorđe Filipović
Đorđe Filipović
ZŽZorica Živković
Zorica Živković

5 May 2021
Verified
Book Chapter
Open access
PDF file
IFIvana Filipovic
Ivana Filipovic
Milan LackovicMilan Lackovic
Milan Lackovic
SMSladjana Mihajlovic
Sladjana Mihajlovic
ĐFĐorđe Filipović
Đorđe Filipović
TBTamara Bakic
Tamara Bakic
ZZZorica Zivkovic
Zorica Zivkovic
Allergic diseases are the most common chronic diseases in children and no complete agreement on effective measures for primary prevention is available. Atopic family history is one of the most important risk factors for the development of asthma. A decline in microbial diversity due to modern lifestyle particularly in urban areas was proposed to have an important role in allergic epidemic. Recent studies are more focused on the specific mode of prevention such as probiotic usage in early pregnancy and infants period. It is well known that the composition of the gastrointestinal microbiota has been postulated to play a role in the development of allergies because it promotes potentially antiallergenic processes: TH1-type immunity, generation of TGF (which has an essential role in suppression of TH2-induced allergic inflammation and induction of oral tolerance), and IgA production, an essential component of mucosal immune defenses. Probiotic interventions administered during pregnancy and breastfeeding offer a unique opportunity to influence a range of important maternal and infant outcomes.

30 March 2017 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
N(Network for Online Registration of Anaphylaxis (NORA)
Network for Online Registration of Anaphylaxis (NORA)
GPGuillaume Pouessel
Guillaume Pouessel
TSThe Anaphylaxis Working Group of the French Allergology SocietyThe Anaphylaxis Working Group of the French Allergology Society
The Anaphylaxis Working Group of the French Allergology SocietyThe Anaphylaxis Working Group of the French Allergology Society
CCClaire Claverie
Claire Claverie
JLJulien Labreuche
Julien Labreuche
CJCarla Jones
Carla Jones

30 April 2019 in Preventive Paediatrics
Verified
Journal Article
Open access
PDF file
MRMarija Radulović
Marija Radulović
DFDjordje Filipović
Djordje Filipović
IFIvana Filipovic
Ivana Filipovic
Food allergy has been defined as adverse reaction to food in which “immunological mechanism have been demonstrated”. The clinical presentation of food allergy involves a large spectrum of symptoms ranging from skin like urticaria, angioedema, atopic eczema, dermatitis, gastrointestinal (vomiting, colic, abdominal pain, diarrhea, constipation), respiratory (rhinorrhea, sneezing, cough, dyspnea). According to a recent review the point prevalence of self-reported food allergy is approximately six times higher than challenge food allergy. A proper diagnosis is necessary for a sufficient and safe management. The core stone of diagnosis of food allergy is a careful dietary history. Mostly food allergies are self reported, but also a great number of tests are available. The most widely used tests for food allergies diagnosis are: skin prick tests (SPT), specific IgE (sIgE), component resolved diagnosis (CRD) and the atopy patch test (APT). Besides food avoidance there is also growing interest in the effectiveness of potential immunomodulatory treatment approaches, including sublingual and oral immunotherapy to induce tolerance, particularly for peanut allergy. Alergija na hranu je definisana kao imunološki posredovana neželjena reakcija na nutritivne alergene. Klinička slika alergije na hranu uključuje širok spektar simptoma u rasponu od kožnih promena kao što su urtikarija, angioedem, ekcem, dermatitis, zatim gastrointestinalnih (povraćanje, kolika, abdominalni bol, dijareja, konstipacija), respiratornih (rinoreja, kihanje, kašalj, dispneja). Prema nedavnom studija , prevalenca klinički dokazane alergije na hranu je približno šest puta manja nego što je slučaj kada govorimo o alergiji na hranu na osnovu anamenstičkih podataka. Pravilna dijagnoza je neophodna za prevenciju ili eventualno lečenje. Osnovdijagnoze alergije treba da bude kombinacije anamnestičkih padataka, kliničke slike i dobro dijazajniranih dijagnostičkih testova. Najčešće korišćeni testovi za dijagnostiku alergija na hranu su: tskin prick testivi kože (SPT), određivanje nivoa specifičnog IgE (sIgE) na nutritivne alergene , dijagnoza dijagnoze komponenti (CRD) i atopijski test (APT). Osim izbegavanja hrane, postoji sve veće interesovanje za efikasnost pristupa imunomodulatornog tretmana, uključujući sublingvalnu i oralnu imunoterapiju da bi se podstakla tolerancija, posebno kada je u pitanju alergiju na kikiriki.

4 October 2017
Verified
Book Chapter
Open access
PDF file
IFIvana Filipovic
Ivana Filipovic
SZSnezana Zivanovic
Snezana Zivanovic
GKGordana Kostić
Gordana Kostić
DFDjordje Filipovic
Djordje Filipovic
MCMarco Caminti
Marco Caminti
ZZZorica Zivkovic
Zorica Zivkovic
Therapy of allergic diseases in children implicates avoidance of allergens, standard pharmacotherapy, and immunotherapy. Immunotherapy is the only treatment for allergic diseases with the ability to change the natural course of the disease, thus stopping its further progression as well as the development of new allergic diseases and new sensibilizations. The objective of this chapter is to give insight into the latest data on immunotherapy in treating children with allergic diseases. Methods: The study involved a search for relevant articles on the MEDLINE and PubMed up to 2017. Results: Numerous studies have shown that the sublingual application of allergen-specific immunotherapy is adequate, safe, and efficient in the therapy of immunoglobulin E (IgE)-mediated allergic diseases of the respiratory tract in children, but there are still some questions to be solved concerning the usage of SLIT in children younger than 5 years old, SLIT for polysensitized patients, duration of SLIT, long-lasting effects of SLIT. Conclusions: In order to improve the clinical efficacy of SLIT, we are looking for new routes of administration, new allergens, new protocols as well as combination of SLIT with other immune modulatory treatments.

1 September 2020 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
DFDejan Filimonovic
Dejan Filimonovic
MLMilan Lackovic
Milan Lackovic
IFIvana Filipovic
Ivana Filipovic
NONatasa Karadzov Orlic
Natasa Karadzov Orlic
VMVesna Mandic Markovic
Vesna Mandic Markovic
SMSladjana Mihajlovic
Sladjana Mihajlovic